IP Library Granted Patent US 7,628,991
Granted Patent B2
US 7,628,991 · App. 11/905,450 · Granted Dec 8, 2009

Use of

Assignee: Institute National de la Recherche Agronomique (INRA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,628,991
App. No.
11/905,450
Granted
Dec 8, 2009
Kind
B2
Abstract

The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.

Claims (3)

1. A method of treating visceral pain induced by colorectal distention comprising administrating to a patient in need thereof an effective amount of a composition comprising lactic acid bacteria of species Lactobacillus farciminis.

2. A method of claim 1 , wherein said patient suffers from a disease selected from the group consisting of Crohn's disease, hemorrhagic rectocolitis, and irritable bowel syndrome.

3. The method of claim 1 , wherein the composition is in the form of foodstuff or a dietary supplement.

Assignments (1)
CHANGE OF NAME Recorded Jun 15, 2021
From: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA)
To: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Reel/Frame 056592/0475 →
Priority Claims (1)
FR 02 03891 · Mar 28, 2002 · national
Continuity (2)
Division 1050925500
Related Publication 20080085268A1 · Apr 10, 2008